Related references
Note: Only part of the references are listed.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration
Inho Choi et al.
ANGIOGENESIS (2013)
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
Y. S. Lee et al.
BRITISH JOURNAL OF CANCER (2012)
Targeting IL-8 in colorectal cancer
Yan Ning et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
Thomas Jamieson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
A. Manzano et al.
SCIENTIFIC WORLD JOURNAL (2012)
Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
Gerardo G. Mackenzie et al.
CANCER PREVENTION RESEARCH (2011)
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Molecular Alterations Associated with Sulindac-Resistant Colon Tumors in ApcMin/+ Mice
Emily J. Greenspan et al.
CANCER PREVENTION RESEARCH (2010)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2-/- ApcMin/+ mouse
Claude M. Nagamine et al.
INFECTION AND IMMUNITY (2008)
Chemokine regulation of atherosclerosis
Jana Barlic et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
A novel, orally active CXCR1/2 receptor antagonist, sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation
Richard W. Chapman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonist
Michael P. Dwyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
DZ Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients
LC Chen et al.
CANCER RESEARCH (2004)
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations
K Yang et al.
CARCINOGENESIS (2003)
Suppression of tumorigenesis in the Apcmin mouse:: down-regulation of β-catenin signaling by a combination of tea plus sulindac
GA Orner et al.
CARCINOGENESIS (2003)
Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice
KP Janssen et al.
GASTROENTEROLOGY (2002)
Delayed wound healing in CXCR2 knockout mice
RM Devalaraja et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Combinatorial chemoprevention of intestinal neoplasia
CJ Torrance et al.
NATURE MEDICINE (2000)
Share Paper
